Medicinova (MNOV) Shares Outstanding (2010 - 2026)
Medicinova (MNOV) posted quarterly Shares Outstanding (Entity) of $49.2 million for Q4 2025, little changed year-over-year from $49.0 million in Q4 2024, and little changed quarter-over-quarter from $49.0 million in Q3 2025.
Medicinova (MNOV) Shares Outstanding (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Shares Outstanding (Entity) for 16 consecutive years, with $49.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) changed 0.36% year-over-year to $49.2 million; the TTM figure through Dec 2025 stood at $49.2 million (changed 0.36% YoY), while the FY2025 annual figure was $49.2 million, changed 0.36% from the prior year.
- Shares Outstanding (Entity) held at $49.2 million in Q4 2025 per MNOV's latest filing, from $49.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $49.2 million in Q4 2025 and bottomed at $48.8 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $49.0 million across 5 years, with a median of $49.0 million in 2022.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) grew 10.89% — and 2023, when it changed 0.0%.
- Medicinova's Shares Outstanding (Entity) stood at $49.0 million in 2021, then advanced by 0.01% to $49.0 million in 2022, then changed by 0.0% to $49.0 million in 2023, then changed by 0.0% to $49.0 million in 2024, then climbed by 0.36% to $49.2 million in 2025.
- Business Quant data shows MNOV's Shares Outstanding (Entity) at $49.2 million in Q4 2025, $49.0 million in Q3 2025, and $49.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | 49.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.22 Mn |
| Dec 31, 2025 | 49.06 Mn |
| Sep 30, 2025 | 49.05 Mn |
| Jun 30, 2025 | 49.05 Mn |
| Mar 31, 2025 | 49.05 Mn |
| Dec 31, 2024 | 49.05 Mn |
| Sep 30, 2024 | 49.05 Mn |
| Jun 30, 2024 | 49.05 Mn |
| Mar 31, 2024 | 49.05 Mn |
| Dec 31, 2023 | 49.05 Mn |
| Sep 30, 2023 | 49.05 Mn |
| Jun 30, 2023 | 49.05 Mn |
| Mar 31, 2023 | 49.05 Mn |
| Dec 31, 2022 | 49.05 Mn |
| Sep 30, 2022 | 49.05 Mn |
| Jun 30, 2022 | 49.05 Mn |
| Mar 31, 2022 | 49.04 Mn |
| Dec 31, 2021 | 48.60 Mn |
| Sep 30, 2021 | 48.99 Mn |
| Jun 30, 2021 | 48.80 Mn |